Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours
![Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma](https://static.hindawi.com/articles/sci/volume-2019/9060152/figures/9060152.fig.002a.jpg)
Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
![Positive expression of mesenchymal stem cell markers (CD105, CD 73 and... | Download Scientific Diagram Positive expression of mesenchymal stem cell markers (CD105, CD 73 and... | Download Scientific Diagram](https://www.researchgate.net/publication/262072141/figure/fig7/AS:614023754158099@1523406079378/Positive-expression-of-mesenchymal-stem-cell-markers-CD105-CD-73-and-CD90-and-negative.png)
Positive expression of mesenchymal stem cell markers (CD105, CD 73 and... | Download Scientific Diagram
![The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy](https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/4612ba60-a599-4c55-9d9f-9d93fc1ac97e/image/be38fa50-a7d0-4ffa-91c7-ae94582f20eb-ufigure-4.png)
The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy
![CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts | Scientific Reports CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-03963-9/MediaObjects/41598_2021_3963_Fig1_HTML.png)
CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts | Scientific Reports
![IJMS | Free Full-Text | Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review IJMS | Free Full-Text | Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review](https://www.mdpi.com/ijms/ijms-22-04804/article_deploy/html/images/ijms-22-04804-g001.png)
IJMS | Free Full-Text | Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review
![Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo | Scientific Reports Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-62205-6/MediaObjects/41598_2020_62205_Fig1_HTML.png)
Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo | Scientific Reports
![PDF] Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma | Semantic Scholar PDF] Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/719bbe173acd20bbe9010fdc83f775b181fed189/4-Figure1-1.png)
PDF] Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma | Semantic Scholar
Endoglin expression level discriminates long-term hematopoietic from short-term clonogenic progenitor cells in the aorta | Haematologica
![Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential - ScienceDirect Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1063458415014041-gr2.jpg)
Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential - ScienceDirect
![The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy](https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/4612ba60-a599-4c55-9d9f-9d93fc1ac97e/image/fe875e3c-22b3-4bae-9efd-891ddbcb19bf-ufigure-3.png)
The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy
![CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma | SpringerLink CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13402-020-00530-8/MediaObjects/13402_2020_530_Fig2_HTML.png)
CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma | SpringerLink
![Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential - ScienceDirect Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1063458415014041-gr1.jpg)